The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 01, 2022

Filed:

Sep. 05, 2014
Applicants:

Sarepta Therapeutics, Inc., Cambridge, MA (US);

Murdoch University, Murdoch, AU;

Inventors:

Stephen Donald Wilton, Applecross, AU;

Sue Fletcher, Bayswater, AU;

Gunnar James Hanson, Cambridge, MA (US);

Richard Keith Bestwick, Corvallis, OR (US);

Assignees:

SAREPTA THERAPEUTICS, INC., Cambridge, MA (US);

MURDOCH UNIVERSITY, Murdoch, AU;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/113 (2010.01); C07F 9/6533 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1137 (2013.01); C07F 9/6533 (2013.01); C12N 2310/11 (2013.01); C12N 2310/315 (2013.01); C12N 2310/3145 (2013.01); C12N 2310/3181 (2013.01); C12N 2310/321 (2013.01); C12N 2310/3231 (2013.01); C12N 2310/3233 (2013.01); C12N 2310/3513 (2013.01); C12N 2320/33 (2013.01); C12Y 302/0102 (2013.01);
Abstract

The present disclosure relates to antisense oligomers and related compositions and methods for inducing exon inclusion as a treatment for glycogen storage disease type II (GSD-II) (also known as Pompe disease, glycogenosis II, acid maltase deficiency (AMD), acid alpha-glucosidase deficiency, and lysosomal alpha-glucosidase deficiency), and more specifically relates to inducing inclusion of exon 2 and thereby restoring levels of enzymatically active acid alpha-glucosidase (GAA) protein encoded by the GAA gene.


Find Patent Forward Citations

Loading…